AGTC-402

DB18433InvestigationalGene Therapies

AGTC-402 is a recombinant adeno-associated virus vector expressing the cyclic nucleotide gated channel alpha subunit (CNGA3).

Also known as
ACHM A3 · ACHM CNGA3 · rAAV2tYF-PR.1-hCNGA3 · recombinant Adeno-associated virus vector expressing CNGA3
Code names
AGTC-402

What you can answer from here — as of April 23, 2025

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of AGTC-402, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In